Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

40 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Triclosan targets lipid synthesis.
McMurry LM, Oethinger M, Levy SB. McMurry LM, et al. Among authors: oethinger m. Nature. 1998 Aug 6;394(6693):531-2. doi: 10.1038/28970. Nature. 1998. PMID: 9707111 No abstract available.
Overexpression of marA, soxS, or acrAB produces resistance to triclosan in laboratory and clinical strains of Escherichia coli.
McMurry LM, Oethinger M, Levy SB. McMurry LM, et al. Among authors: oethinger m. FEMS Microbiol Lett. 1998 Sep 15;166(2):305-9. doi: 10.1111/j.1574-6968.1998.tb13905.x. FEMS Microbiol Lett. 1998. PMID: 9770288
It inhibits lipid biosynthesis in Escherichia coli, probably by action upon enoyl reductase (FabI) (McMurry, L.M., Oethinger, M. and Levy, S.B. (1988) Nature 394, 531-532). ...
It inhibits lipid biosynthesis in Escherichia coli, probably by action upon enoyl reductase (FabI) (McMurry, L.M., Oethinger, …
Ineffectiveness of topoisomerase mutations in mediating clinically significant fluoroquinolone resistance in Escherichia coli in the absence of the AcrAB efflux pump.
Oethinger M, Kern WV, Jellen-Ritter AS, McMurry LM, Levy SB. Oethinger M, et al. Antimicrob Agents Chemother. 2000 Jan;44(1):10-3. doi: 10.1128/aac.44.1.10-13.2000. Antimicrob Agents Chemother. 2000. PMID: 10602715 Free PMC article.
Non-target gene mutations in the development of fluoroquinolone resistance in Escherichia coli.
Kern WV, Oethinger M, Jellen-Ritter AS, Levy SB. Kern WV, et al. Among authors: oethinger m. Antimicrob Agents Chemother. 2000 Apr;44(4):814-20. doi: 10.1128/aac.44.4.814-820.2000. Antimicrob Agents Chemother. 2000. PMID: 10722475 Free PMC article.
Overexpression of the marA or soxS regulatory gene in clinical topoisomerase mutants of Escherichia coli.
Oethinger M, Podglajen I, Kern WV, Levy SB. Oethinger M, et al. Antimicrob Agents Chemother. 1998 Aug;42(8):2089-94. doi: 10.1128/AAC.42.8.2089. Antimicrob Agents Chemother. 1998. PMID: 9687412 Free PMC article.
Among 25 cyclohexane-tolerant strains detected by a screen for increased organic solvent tolerance (M. Oethinger, W. V. Kern, J. ...
Among 25 cyclohexane-tolerant strains detected by a screen for increased organic solvent tolerance (M. Oethinger, W. V. Kern, …
Association of organic solvent tolerance and fluoroquinolone resistance in clinical isolates of Escherichia coli.
Oethinger M, Kern WV, Goldman JD, Levy SB. Oethinger M, et al. J Antimicrob Chemother. 1998 Jan;41(1):111-4. doi: 10.1093/jac/41.1.111. J Antimicrob Chemother. 1998. PMID: 9511045
Characterization of blaKPC-containing Klebsiella pneumoniae isolates detected in different institutions in the Eastern USA.
Endimiani A, Hujer AM, Perez F, Bethel CR, Hujer KM, Kroeger J, Oethinger M, Paterson DL, Adams MD, Jacobs MR, Diekema DJ, Hall GS, Jenkins SG, Rice LB, Tenover FC, Bonomo RA. Endimiani A, et al. Among authors: oethinger m. J Antimicrob Chemother. 2009 Mar;63(3):427-37. doi: 10.1093/jac/dkn547. Epub 2009 Jan 20. J Antimicrob Chemother. 2009. PMID: 19155227 Free PMC article.
Colonization and infection with fluoroquinolone-resistant Escherichia coli among cancer patients: clonal analysis.
Oethinger M, Jellen-Ritter AS, Conrad S, Marre R, Kern WV. Oethinger M, et al. Infection. 1998 Nov-Dec;26(6):379-84. doi: 10.1007/BF02770840. Infection. 1998. PMID: 9861564
Fluoroquinolone resistance of Escherichia coli at a cancer center: epidemiologic evolution and effects of discontinuing prophylactic fluoroquinolone use in neutropenic patients with leukemia.
Kern WV, Klose K, Jellen-Ritter AS, Oethinger M, Bohnert J, Kern P, Reuter S, von Baum H, Marre R. Kern WV, et al. Among authors: oethinger m. Eur J Clin Microbiol Infect Dis. 2005 Feb;24(2):111-8. doi: 10.1007/s10096-005-1278-x. Eur J Clin Microbiol Infect Dis. 2005. PMID: 15714332
gyrA mutations in high-level fluoroquinolone-resistant clinical isolates of Escherichia coli.
Conrad S, Oethinger M, Kaifel K, Klotz G, Marre R, Kern WV. Conrad S, et al. Among authors: oethinger m. J Antimicrob Chemother. 1996 Sep;38(3):443-55. doi: 10.1093/jac/38.3.443. J Antimicrob Chemother. 1996. PMID: 8889719
40 results
Jump to page
Feedback